Effect of hydroxyapatite-based biomaterials on human osteoblast phenotype.
The present study evaluated human primary osteoblasts and two different osteoblast-like cell lines behaviour when cultured in presence of different hydroxyapatite-based (HA) biomaterials (SINTlife-FIN-CERAMICA S.p.a., Faenza, Italy; Bio-Oss, Geistlich Biomaterials, Woulhusen, Switzerland; Biostite-GABA Vebas, San Giuliano Milanese, MI, Italy), focusing attention on the effect of HA/Biostite in terms of modulation of osteoblastic differentiation. Analysis were about adhesion, proliferation and mineralization activity. Runt-related transcription factor 2 (Runx2), Estrogen Receptor alpha (ERalfa) expression and alkaline phosphatase activity (ALP) were measured as osteoblastic differentiation markers. Determination of viable cells was done with MTT colorimetric assay. Scanning electron microscopy (SEM) analysis was performed on biomaterial-treated cells. All hydroxyapatite-based biomaterials didn't affect cells morphology and viability, whereas only presence of HA/Biostite improved cells adhesion, growth and differentiation. Adhesion and spreading of the primary cells on HA/Biostite were the same showed by two different osteoblast-like cell lines. These results have important implications for both tissue-engineered bone grafts and enhancement of HA implants performance, to develop new teeth's supporting structure therapies and replacement.
Trombelli
L
L
Medico-Surgical Disciplines of Communication and Behaviour Department, Research Centre for the Study of Periodontal Diseases, University of Ferrara, Ferrara, Italy.
Penolazzi
L
L
Torreggiani
E
E
Farina
R
R
Lambertini
E
E
Vecchiatini
R
R
Piva
R
R
D001672:Biocompatible Materials / Q000494:pharmacology*; D002478:Cells, Cultured; D017886:Durapatite / Q000494:pharmacology*; D006801:Humans; D010006:Osteoblasts / Q000187:drug effects*; D010641:Phenotype
D001672:Biocompatible Materials; D017886:Durapatite